Literature DB >> 33884438

[Kerion Celsi due to Microsporum canis infection].

A Chiriac1,2,3, C Birsan2, M Mares4, Uwe Wollina5.   

Abstract

Tinea capitis is seen world-wide among children up to 12 years. The most severe type is Kerion Celsi with painful abscesses and lymphadenopathy. We report on an 11-year-old boy with Kerion Celsi, who was initially treated using antibiotics under the common misdiagnosis of a bacterial infection. Mycological investigations could identify Microsporum canis. The patient was treated orally with griseofulvin, which resulted in complete mycological remission after 8 weeks. Cicatrical alopecia, however, could not be prevented. Purulent infections of the scalp should lead to early mycological diagnostics in children.

Entities:  

Keywords:  Griseofulvin; Lymphadenopathy; Mycological diagnostics; Pseudopélade Brocq; Tinea capitis

Year:  2021        PMID: 33884438     DOI: 10.1007/s00105-021-04817-1

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  3 in total

1. 

Authors:  Peter Mayser; Pietro Nenoff; Dieter Reinel; Dietrich Abeck; Jochen Brasch; Georg Daeschlein; Isaak Effendy; Gabriele Ginter-Hanselmayer; Yvonne Gräser; Uta-Christina Hipler; Peter Höger; Annette Kolb-Mäurer; Hagen Ott; Martin Schaller; Miriam Zidane
Journal:  J Dtsch Dermatol Ges       Date:  2020-02       Impact factor: 5.584

2.  Genes Encoding Proteolytic Enzymes Fungalysin and Subtilisin in Dermatophytes of Human and Animal Origin: A Comparative Study.

Authors:  Engin Kaplan; Serpil Gonca; Hazal Kandemir; Aylin Döğen; Süleyha Hilmioğlu-Polat; Macit Ilkit; Reiko Tanaka; Takashi Yaguchi; Silke Uhrlaβ; Pietro Nenoff
Journal:  Mycopathologia       Date:  2019-08-02       Impact factor: 2.574

3.  Mycology - an update part 2: dermatomycoses: clinical picture and diagnostics.

Authors:  Pietro Nenoff; Constanze Krüger; Jörg Schaller; Gabriele Ginter-Hanselmayer; Rudolf Schulte-Beerbühl; Hans-Jürgen Tietz
Journal:  J Dtsch Dermatol Ges       Date:  2014-09       Impact factor: 5.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.